Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cognition Therapeutics to Present at the TD Cowen Health Care Conference
-
NFI subsidiary Alexander Dennis’ next-gen Enviro400EV confirmed as the most efficient battery-electric double-decker tested via Zemo in the UK
-
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance
-
Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
-
Aterian Further Strengthens Its Balance Sheet With Extension Of Its Credit Facility
-
Blackwells Capital Releases its Vision for the Future of Technology at Disney
-
Lilium Gears Up for Production of the Lilium Jet’s Revolutionary Electric Propulsion Units
-
TINA.org Investigation Finds Pervasive Deceptive Earnings Claims in MLM Industry
-
AirBoss Announces Corporate Update and Preview of Annual 2023 Results
-
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmac
-
Ranchero Provides Update on the Disposition of Its Santa Daniela Property and Pinchi Lake Option Agreement
-
Applied Materials Expands Patterning Solutions Portfolio for Angstrom Era Chipmaking
-
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
-
Ascent Solar Technologies to Fly Space Solar Modules on NASA’s Upcoming LISA-T Mission
-
Clear Blue Technologies Provides Q4 2023 Corporate Update
-
Orion Group Financial Statement documents 2023, Corporate Governance Statement and Remuneration Report published
-
Wearable Devices to Showcase Its Neural Gesture Control Technology at MWC Barcelona 2024
-
Fengate announces key leadership appointments for firm’s real estate business
-
Freename Launches NOTO: The Protocol That Makes Web3 Internet Accessible and Interoperable to All
-
Freename Launches NOTO: The Protocol That Makes Web3 Internet Accessible and Interoperable to All
-
Gilat Presents Fourth Quarter and Full Year 2023 Results
-
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
-
Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
-
Uniti Group Inc. Announces Completion of New ABS Bridge Facility and Recent Asset Sales
-
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
-
Reunion Gold Significantly Increases Ounces and Grade in an Updated Mineral Resource Estimate at the Oko West Project in Guyana, With an Indicated Resource of 4.3 Million Ounces of Gold at 2.05 g/t an
-
Helium Evolution Provides Operations Update Featuring Preliminary Production Test Data from Two Helium Discovery Wells
-
Microbix Announces Issuance of Stock Options
-
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
-
United Lithium Announces the Commencement of OTCQX Trading
-
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)
-
Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
-
American Lithium Files Robust PEA for Falchani Hard Rock Lithium Project with Highlights Including a Tripling of After-tax NPV8 to US$5.11 Billion
-
Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
-
Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)
-
Genius Group expands AI-Powered Genius University
-
Pilgrim’s Pride Reports Fourth Quarter and Year-End 2023 Results
-
Mesoblast Financial Results and Corporate Update Webcast
-
Interactive Strength Inc. (Nasdaq: TRNR) Enters Into Exclusive Worldwide Distribution Agreement With WOODWAY to Sell and Distribute CLMBR
-
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
-
Micron Commences Volume Production of Industry-Leading HBM3E Solution to Accelerate the Growth of AI
-
Hydreight Partners with Ola Digital Health, an Independent, National Pharmacy Network to Provide Health and Wellness Services in Store
-
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
-
OTC Markets Group Welcomes Graphene Manufacturing Group Ltd. to OTCQX
-
Marquette National Corporation Reports 2023 Annual Results
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Shattuck Labs Announces Participation in Upcoming March Conferences
-
OTC Markets Group Welcomes United Lithium Corp. to OTCQX
-
Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US
-
Form 8.3 - [SAIETTA GROUP PLC - Opening Disclosure - 23 02 2024] - (CGAML)

